pcos and glp 1 medications Can GLP-1s Help Treat PCOS? OB-GYNs Explain Why They're Hopeful GLP-1 medications emerging as PCOS

Ethics declarations Competing interests K.R.T

Current and resolved drug shortages and discontinuations reported to the FDA, Food and Drug Administration (2024) Regulatory framework for compounded preparations, National Academies Press (2020) Clinical and legal considerations in pharmaceutical compounding, The Journal of Clinical and Aesthetic Dermatology (2023) FDA alerts health care providers, compounders, and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) Medications containing semaglutide marketed for Type 2 diabetes or weight loss, Food and Drug Administration (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Pharmacoepidemiol Drug Saf 27(8):867871

The connections between diabetes, SARS-CoV-2 infection, and the development of pulmonary fibrosis were then investigated further using experiments in mice